As of 30 June 2026, AstraZeneca PLC reported a total of 1,551,024,534 ordinary shares with voting rights. No shares are held in treasury. AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines.
